Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Sensorion (ALSEN) EUR0.1

Sell:€2.01 Buy:€2.03 Change: €0.1 (4.48%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€2.01
Buy:€2.03
Change: €0.1 (4.48%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€2.01
Buy:€2.03
Change: €0.1 (4.48%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Sensorion SA is a France-based company principally engaged in the biopharmaceutical sector. The Company is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The Company develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

Contact details

Address:
375, rue du Professeur Joseph Blayac
MONTPELLIER
34080
France
Telephone:
+33 (4) 67207730
Website:
www.sensorion-pharma.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALSEN
ISIN:
FR0012596468
Market cap:
€164.26 million
Shares in issue:
58.56 million
Sector:
Biotechnology
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
n/a

Key personnel

  • Edwin Moses
    Chairman of the Board
  • Laurent Nguyen
    Chief Executive Officer
  • Aurore Brugeaud
    Operations Manager
  • Jonas Dyhrfjeld-Johnsen
    Senior Project Leader
  • Geraldine Honnet
    Chief Medical Officer
  • Eric Wersinger
    Project Leader

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.